<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34009082</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2167-9223</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>7-8</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</Title><ISOAbbreviation>Amyotroph Lateral Scler Frontotemporal Degener</ISOAbbreviation></Journal><ArticleTitle>Expanding the clinical and genetic spectrum of <i>SQSTM1</i>-related disorders in family with personality disorder and frontotemporal dementia.</ArticleTitle><Pagination><StartPage>552</StartPage><EndPage>560</EndPage><MedlinePgn>552-560</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21678421.2021.1927101</ELocationID><Abstract><AbstractText><i>Objective:</i><i>SQSTM1</i>-variants associated with frontotemporal lobar degeneration have been described recently. In this study, we investigated a heterozygous in-frame duplication c.436_462dup p. (Pro146_Cys154dup) in the <i>SQSTM1</i> gene in a family with a new phenotype characterized by a personality disorder and behavioral variant frontotemporal dementia (bvFTD). We review the literature on frontotemporal dementia (FTD) associated with <i>SQSTM1</i>. <i>Methods:</i> The index case and relatives were described, and a genetic study through Whole Exome Sequencing was performed. The literature was reviewed using Medline and Web of Science. Case reports, case series, and cohort studies were included if they provided information on <i>SQSTM1</i> mutations associated with FTD. <i>Results</i>: Our patient is a 70-year-old man with a personality disorder since youth, familial history of dementia, and personality disorders with a 10-year history of cognitive decline and behavioral disturbances. A diagnosis of probable bvFTD was established, and the in-frame duplication c.436_462dup in the <i>SQSTM1</i> gene was identified. Segregation analysis in the family confirmed that both affected sons with personality disorder were heterozygous carriers, but not his healthy 65-year-old brother. A total of 14 publications about 57 patients with <i>SQSTM1</i>-related FTD were reviewed, in which the bvFTD subtype was the main phenotype described (66.6%), with a predominance in men (63%) and positive family history in 61.4% of the cases. <i>Conclusions:</i> We describe a heterozygous in-frame duplication c.436_462dup p.(Pro146_Cys154dup) in the <i>SQSTM1</i> gene, which affects the zinc-finger domain of p62, in a family with a personality disorder and bvFTD, expanding the genetics and clinical phenotype related to <i>SQSTM1</i>.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Llamas-Velasco</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neurology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Group of Neurodegenerative Diseases, Instituto de Investigaci&#xf3;n Hospital 12 de Octubre (i&#x2009;+&#x2009;12).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arteche-L&#xf3;pez</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Genetic Service, Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe9;ndez-Guerrero</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puertas Mart&#xed;n</LastName><ForeName>Ver&#xf3;nica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Neurology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Internacional de la Rioja, Logro&#xf1;o, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quesada Espinosa</LastName><ForeName>Juan Francisco</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Genetic Service, Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lezana Rosales</LastName><ForeName>Jose Miguel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Genetic Service, Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-S&#xe1;nchez</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Group of Neurodegenerative Diseases, Instituto de Investigaci&#xf3;n Hospital 12 de Octubre (i&#x2009;+&#x2009;12).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanco-Palmero</LastName><ForeName>Victor Antonio</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Neurology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Group of Neurodegenerative Diseases, Instituto de Investigaci&#xf3;n Hospital 12 de Octubre (i&#x2009;+&#x2009;12).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palma Milla</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Genetic Service, Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrero-San Mart&#xed;n</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Group of Neurodegenerative Diseases, Instituto de Investigaci&#xf3;n Hospital 12 de Octubre (i&#x2009;+&#x2009;12).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borrego-Hern&#xe1;ndez</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Group of Neurodegenerative Diseases, Instituto de Investigaci&#xf3;n Hospital 12 de Octubre (i&#x2009;+&#x2009;12).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Networking Centre on Rare Diseases (CIBERER).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Redondo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Group of Neurodegenerative Diseases, Instituto de Investigaci&#xf3;n Hospital 12 de Octubre (i&#x2009;+&#x2009;12).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Networking Centre on Rare Diseases (CIBERER).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Mart&#xed;nez</LastName><ForeName>David Andr&#xe9;s</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Neurology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Group of Neurodegenerative Diseases, Instituto de Investigaci&#xf3;n Hospital 12 de Octubre (i&#x2009;+&#x2009;12).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Universidad Complutense, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villarejo-Galende</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Group of Neurodegenerative Diseases, Instituto de Investigaci&#xf3;n Hospital 12 de Octubre (i&#x2009;+&#x2009;12).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Universidad Complutense, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Amyotroph Lateral Scler Frontotemporal Degener</MedlineTA><NlmUniqueID>101587185</NlmUniqueID><ISSNLinking>2167-8421</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C099718">SQSTM1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071456">Sequestosome-1 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="Y">Frontotemporal Lobar Degeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010554" MajorTopicYN="N">Personality Disorders</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071456" MajorTopicYN="N">Sequestosome-1 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SQSTM1</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">personality disorder</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>19</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34009082</ArticleId><ArticleId IdType="doi">10.1080/21678421.2021.1927101</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>